These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 1234422)
1. [Therapeutic action of glucagon on pathological states of the myocardium, especially on specific conduction tissue disorders]. Sanna S; Leo P; Netter R Boll Soc Ital Cardiol; 1975; 20(10):1233-49. PubMed ID: 1234422 [No Abstract] [Full Text] [Related]
2. Effects of glucagon on atrio-ventricular conduction in man. Gavrilescu S; Cotoi S; Pop T G Ital Cardiol; 1972; 2(5):612-9. PubMed ID: 5079019 [No Abstract] [Full Text] [Related]
3. [Glucagon in the therapy of cardiac insufficiency. Clinical study of 50 treated cases]. Lotto A; Sanna GP; Bomanto B; Bossi M; Rota M G Ital Cardiol; 1973; 3(3):405-13. PubMed ID: 4766974 [No Abstract] [Full Text] [Related]
4. The role of glucagon in cardiac therapy. Parmley WW N Engl J Med; 1971 Sep; 285(14):801-2. PubMed ID: 5567270 [No Abstract] [Full Text] [Related]
5. A role for glucagon in cardiac therapy. Parmley WW; Sonnenblick EH Am J Med Sci; 1969 Oct; 258(4):224-9. PubMed ID: 4309903 [No Abstract] [Full Text] [Related]
6. [Studies of the action of glucagon on phases of ventricular systole and excito-conducting function of the heart in patients with cardiac insufficiency]. Tacu V; Casetti M; Rucinski S; Platon M Rev Med Chir Soc Med Nat Iasi; 1972; 76(1):21-30. PubMed ID: 5016783 [No Abstract] [Full Text] [Related]
7. [Glucagon in the acute stage of myocardial infarct]. Waremboug H; Bertrand ME; Ducloux G; Pauchant M; Ginestet A; Ketelers JY; Carre A; Delbecque H Arch Mal Coeur Vaiss; 1973 Apr; 66(4):449-56. PubMed ID: 4200209 [No Abstract] [Full Text] [Related]
8. [Experience with using glucagon in acute myocardial infarct]. Golikov AP; Berestov AA; Abdrakhmanov VR; Bobkov AI Kardiologiia; 1974 Feb; 14(2):37-42. PubMed ID: 4825009 [No Abstract] [Full Text] [Related]
9. [Lidocaine and conduction disorders (3 illustrative cases)]. Dimitriu CG; Karassi A; Gavrilă F Med Interna (Bucur); 1972 Jan; 24(1):9-13. PubMed ID: 5021768 [No Abstract] [Full Text] [Related]
10. [Polycardiographic evaluation of left ventricular contraction following glucagon administration to patients with chronic circulatory failure]. Szczeklik J; Dubiel J; Pyzik Z Pol Tyg Lek; 1976 Oct; 31(40):1709-12. PubMed ID: 980998 [No Abstract] [Full Text] [Related]
11. [On the circulatory effect of the coronary dilator PETN]. Tilsner V Med Klin; 1969 Jun; 64(24):1120-3. PubMed ID: 5809489 [No Abstract] [Full Text] [Related]
12. [Cardiological use of glucagon-zinc-protamine in diabetes]. Bruni B Minerva Med; 1972 Nov; 63(83):4513-9. PubMed ID: 4404792 [No Abstract] [Full Text] [Related]
13. [Hemodynamic effects of glucagon in acute myocardial infarct, total A-V block and mitral stenosis]. Gavrilescu S; Streian C; Pop T; Vicaş E Med Interna (Bucur); 1971 May; 23(5):573-82. PubMed ID: 5567983 [No Abstract] [Full Text] [Related]
14. [Effects of a new anti-arrhythmic drug, bunaftine, on intra-atrial, atrio-ventricular and intraventricular conduction of the stimulus]. Grazi S; Romano S; Bonazzi O; Pozzoni L; Cavoretto D; Gardumi M; Sardella F Cardiol Prat; 1974; 25(3):213-8. PubMed ID: 4434374 [No Abstract] [Full Text] [Related]
15. [Cardiovascular effects of glucagon]. Seitz N Internist (Berl); 1971 May; 12(5):222-3. PubMed ID: 4931507 [No Abstract] [Full Text] [Related]
16. Glucagon: its enhancement of atrioventricular nodal pacemaker activity and failure to increase ventricular automaticity in dogs. Lucchesi BR; Stutz DR; Winfield RA Circ Res; 1969 Aug; 25(2):183-90. PubMed ID: 5806161 [No Abstract] [Full Text] [Related]
17. [Cardiovascular effects of glucagon]. Gavrilescu S; Streian C Med Interna (Bucur); 1972 Apr; 24(4):441-50. PubMed ID: 5027789 [No Abstract] [Full Text] [Related]
18. [Effect of ildamen on the heart conduction system in ischemic heart disease patients]. Shilov AM; Borisov VG Farmakol Toksikol; 1987; 50(5):34-6. PubMed ID: 2891566 [TBL] [Abstract][Full Text] [Related]
19. [Indications and mode of action of digitalis glycosides. A new hemisynthetic compound: formyl 16 gytoxin]. Chiche P; Derai C; Melman S; Chekler P Therapeutique; 1970 Jan; 46(1):17-24. PubMed ID: 5437772 [No Abstract] [Full Text] [Related]